Volatile organic compounds (VOCs) are produced by the human metabolism, inflammation
and gut microbiota and form the basis of innovative volatomics research. VOCs detected …

The diagnosis of inflammatory bowel disease (IBD) remains a challenging task despite
significant increase in the understanding of the disease aetiology and pathogenesis. Recent …

Background The aetiology of inflammatory bowel disease (IBD) remains poorly understood.
Recent evidence suggests an important role of gut microbial dysbiosis in IBD, and this may …

Background Irritable bowel syndrome (IBS) is a prevalent gastrointestinal disease
characterized by intermittent abdominal pain with altered bowel habits. Due to the …

The investigation of a novel, cheaper method of diagnosing inflammatory bowel disease
(IBD) is an area of active research. Recently, investigations into the metabolomic profile of …

Background Irritable bowel syndrome (IBS) is a chronic gastrointestinal disorder for which
no diagnostic tools are currently available. Patients are diagnosed using the Rome IV …

Introduction: Inflammatory bowel disease (IBD) is a common disease with significant
morbidity. Noninvasive diagnostic techniques are lacking in IBD. Currently, fecal calprotectin …

Background The diagnosis of irritable bowel syndrome (IBS) is challenging because of its
heterogeneity and multifactorial pathophysiology. No reliable biomarkers of IBS have been …

Introduction Early inflammatory bowel disease (IBD) diagnosis remains a clinical challenge.
Volatile organic compounds (VOCs) have shown distinct patterns in Crohn's disease (CD) …

Increasing interest is noticed in the potential of volatile organic compound (VOC) analysis as
non-invasive diagnostic biomarker in clinical medical practice. The spectrum of VOCs …